GB1426353A - 15alpha,16alpha-methylene-5alpha-androstanes - Google Patents

15alpha,16alpha-methylene-5alpha-androstanes

Info

Publication number
GB1426353A
GB1426353A GB681973A GB681973A GB1426353A GB 1426353 A GB1426353 A GB 1426353A GB 681973 A GB681973 A GB 681973A GB 681973 A GB681973 A GB 681973A GB 1426353 A GB1426353 A GB 1426353A
Authority
GB
United Kingdom
Prior art keywords
methylene
acetoxy
prepared
androstan
give
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB681973A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of GB1426353A publication Critical patent/GB1426353A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

1426353 15,16-Methylene-androstane compounds SCHERING AG 12 Feb 1973 [11 Feb 1972] 6819/73 Heading C2U Novel steroids of the formula (wherein R is H, acyl, C 1-4 alkyl or an oxygencontaining heterocyclic group and C<SP>1</SP>-C<SP>2</SP> is a single or double bond between the 1- and 2- carbon atoms) are prepared by chemical or microbiological oxidation of the corresponding ring A-saturated 3#-hydroxy-steroids containing a protected 17#-hydroxy group, followed, if desired, by #<SP>1</SP>-dehydrogenation (for example by bromination and dehydrobromination) and/or, if desired or necessary, by conversion to a free 17#-ol which if desired may subsequently be esterified or etherified. 17# - Benzoyloxy - 15α,16α - methylene - 5α- androstan-3#-ol is prepared by oxygenating 3#- acetoxy - 5α - pregn - 16 - en - 20 - one to give 17α - hydroxy - 3# - acetoxy - 5α - pregn - 15- en - 20 - one, reducing this to the 20-ol. refluxing this in a solvent with a zinc-copple couple and methylene iodide to give 3#-acetoxy-15α,16α- methylene - 5α - pregnane - 17α,20# - diol, oxidizing this with periodic acid to give 3#-acetoxy- 15α,16α - methylene - 5α - androstan - 17 - one, reducing this to the 17#-ol, converting this to the 17-benzoate and hydrolysing the 3-acetoxy group. 17# - Tetrahydropyranyloxy - 15α,16α- methylene - 5α - androstan - 3# - ol is prepared by hydrolysis of 17#-tetrahydropyranyloxy-3#- acetoxy - 15α, 16α - methylene - 5α - androstane, in turn prepared by etherification of the corresponding 17#-ol. The novel steroids are androgenic and anabolic agents and may be made up into pharmaceutical compositions with suitable carriers.
GB681973A 1972-02-11 1973-02-12 15alpha,16alpha-methylene-5alpha-androstanes Expired GB1426353A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19722207422 DE2207422A1 (en) 1972-02-11 1972-02-11 15ALPHA, 16ALPHA-METHYLENE-5ALPHA-ANDROSTANE

Publications (1)

Publication Number Publication Date
GB1426353A true GB1426353A (en) 1976-02-25

Family

ID=5836212

Family Applications (1)

Application Number Title Priority Date Filing Date
GB681973A Expired GB1426353A (en) 1972-02-11 1973-02-12 15alpha,16alpha-methylene-5alpha-androstanes

Country Status (9)

Country Link
JP (1) JPS4886855A (en)
AT (1) AT323345B (en)
BE (1) BE795239A (en)
CH (1) CH588506A5 (en)
DE (1) DE2207422A1 (en)
DK (1) DK130988B (en)
FR (1) FR2181720B1 (en)
GB (1) GB1426353A (en)
NL (1) NL7301923A (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1643035B2 (en) * 1967-08-11 1976-01-15 Schering Ag, 1000 Berlin Und 4619 Bergkamen 15BETA, 16BETA-METHYLEN-5ALPHA -ANDROST-L-ENE, PROCESS FOR THEIR MANUFACTURING AND THE PRODUCTS CONTAINED

Also Published As

Publication number Publication date
DK130988C (en) 1975-10-13
CH588506A5 (en) 1977-06-15
FR2181720A1 (en) 1973-12-07
FR2181720B1 (en) 1975-11-21
DK130988B (en) 1975-05-12
JPS4886855A (en) 1973-11-15
AT323345B (en) 1975-07-10
DE2207422A1 (en) 1973-08-16
BE795239A (en) 1973-08-09
NL7301923A (en) 1973-08-14

Similar Documents

Publication Publication Date Title
GB1434919A (en) 3alpha-hydroxy androstanes
GB1426353A (en) 15alpha,16alpha-methylene-5alpha-androstanes
FI853560L (en) FRAMEWORK FOR FRAMING PROCESSING.
GB1472922A (en) Pregnanoic acid derivatives
GB1447247A (en) Beta-3-oxo-7alpha-acylthio-17beta-hydroxy-4-androsten- or estren 17alpha-yl-propionic acid y-lactones and intermediates in the production thereof
GB1206874A (en) 7alpha-METHYL-6&amp;beta,19-OXIDO-ANDROSTANE COMPOUNDS
GB1504410A (en) 11beta-fluoroandrostenes
GB1383334A (en) 15alpha,16alpha-methylene-steroids
GB898295A (en) Improvements in or relating to steroids and the manufacture thereof
SE7514513L (en) 15 ALFA, 16 ALFA-METHYLENE-4-OSTRENE-17BETA OLES FOR USE AS CONTRACTIVE AGENT
US3376294A (en) 6-fluoro-16-methylene steroid compounds and process
GB1260398A (en) NEW 18-METHYL-5alpha-H-ANDROSTANES
GB1481964A (en) Process for the manufacture of 17beta-oxalylsteroids
ES379193A1 (en) 01beta-METHYL-19-NORPREGNENE COMPOUNDS
GB1527249A (en) 6-fluoro-16-methyl-pregna-1,4,8-triene-3,20-diones
US3123600A (en) Reaction sequence b
GB1289852A (en)
US3351637A (en) 12, 20-dimethyl-delta4-pregnene-3, 20-dione steroids and derivatives thereof
GB1289020A (en)
GB1071207A (en) Improvements in or relating to 6,6-ethylene corticoids
GB1450693A (en) Beta-3-oxo-7alpha-acylthio-17beta-hydroxy-4-androsten-or estren- 17alpha-yl- propionic acidderivatives
ES314750A1 (en) 6 halo-9beta,10alpha-steroids
GB959792A (en) Improvements in or relating to steroids
GB1265393A (en)
GB1264050A (en) Steroidal lactones

Legal Events

Date Code Title Description
PS Patent sealed
PCNP Patent ceased through non-payment of renewal fee